Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Zhejiang Hisun Pharmaceutical Co Days Inventory?
Zhejiang Hisun Pharmaceutical CoSHSE:600267 +1.02%58 Days Inventory is 118.19 as of Mar. 2026, which is 3% above its 10-year median of 115.02. GuruFocus rates SHSE:600267 with a GF Score™ of 58/100 and a GF Value™ of ¥8.85 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 922 Drug Manufacturers companies, Zhejiang Hisun Pharmaceutical Co ranks better than 75.6% on this metric.
The historical rank and industry rank for Zhejiang Hisun Pharmaceutical Co's Days Inventory or its related term are showing as below:
SHSE:600267'
s Days Inventory Range Over the Past 10 Years
Min: 103.67 Med: 115.02 Max: 128.29
Current: 108.08
During the past 13 years, Zhejiang Hisun Pharmaceutical Co's highest Days Inventory was 128.29. The lowest was 103.67. And the median was 115.02.
SHSE:600267's Days Inventory is ranked better than 75.6% of 922
companies
in the Drug Manufacturers industry
Industry Median: 164.72
vs SHSE:600267: 108.08
Inventory Turnover measures how fast the company turns over its inventory within a year.
Zhejiang Hisun Pharmaceutical Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.77.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zhejiang Hisun Pharmaceutical Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.64.
Zhejiang Hisun Pharmaceutical Co (SHSE:600267) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Zhejiang Hisun Pharmaceutical Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zhejiang Hisun Pharmaceutical Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Zhejiang Hisun Pharmaceutical Co Days Inventory Related Terms
Zhejiang Hisun Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Hisun Pharmaceutical Co Days Inventory Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Hisun Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Hisun Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhejiang Hisun Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Zhejiang Hisun Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Hisun Pharmaceutical Co (SHSE:600267) has a Days Inventory of 118.19 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zhejiang Hisun Pharmaceutical Co and its competitors. This is near median its historical median of 115.02. Over the past decade, Zhejiang Hisun Pharmaceutical Co's Days Inventory has ranged from 103.67 to 128.29. According to the industry distribution chart, Zhejiang Hisun Pharmaceutical Co ranks #225 out of 922 companies in the Drug Manufacturers industry, placing it in the top 24.4%.
Is Zhejiang Hisun Pharmaceutical Co's Days Inventory too high?
Zhejiang Hisun Pharmaceutical Co's current Days Inventory of 118.19 is near median its 10-year median of 115.02. Over the past 10 years, this metric has ranged from a low of 103.67 to a high of 128.29. The Drug Manufacturers industry median Days Inventory is 164.72. Zhejiang Hisun Pharmaceutical Co's value of 118.19 is 28.2% below this industry median. Based on the distribution chart, Zhejiang Hisun Pharmaceutical Co ranks #225 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Hisun Pharmaceutical Co has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Hisun Pharmaceutical Co's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zhejiang Hisun Pharmaceutical Co ranks #225 out of 922 companies for Days Inventory. This places Zhejiang Hisun Pharmaceutical Co in the top 24% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.72. Zhejiang Hisun Pharmaceutical Co's value of 118.19 is 28.2% below this benchmark. Historically, Zhejiang Hisun Pharmaceutical Co's own Days Inventory has ranged from 103.67 to 128.29 over the past decade. While the company's 10-year median is 115.02 vs. the industry median of 164.72, Zhejiang Hisun Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.72, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Hisun Pharmaceutical Co's current Days Inventory of 118.19 is 28.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zhejiang Hisun Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Hisun Pharmaceutical Co's current Days Inventory is 118.19, which is near median its own 10-year median of 115.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Hisun Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Hisun Pharmaceutical Co (SHSE:600267) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥8.85, compared to a current price of ¥11.84 — trading 33.8% above its estimated fair value. The current Days Inventory is 118.19, which is near median its 10-year median of 115.02 and 28.2% below the Drug Manufacturers industry median of 164.72. Zhejiang Hisun Pharmaceutical Co's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Zhejiang Hisun Pharmaceutical Co (SHSE:600267), the current Days Inventory is 118.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Hisun Pharmaceutical Co (SHSE:600267) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Hisun Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥11.84 is trading 33.8% above its estimated GF Value™ of ¥8.85.
GuruFocus considers Zhejiang Hisun Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for SHSE:600267:
Days Inventory: 118.19 (near median its 10-year median of 115.02)
GF Value™: ¥8.85 vs. price of ¥11.84 (33.8% above fair value)
Industry Position: 28.2% below the Drug Manufacturers median (#225 of 922)
No single metric tells the full story. See the SHSE:600267 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Hisun Pharmaceutical Co Business Description
Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.
58GF Score
Get the complete analysis for SHSE:600267
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600267 has been successfully added to your 
